Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
beta blocker |
| gptkbp:approvalYear |
1997
|
| gptkbp:ATCCode |
C08CA13
|
| gptkbp:bioavailability |
10%
|
| gptkbp:CASNumber |
132866-11-6
|
| gptkbp:contraindication |
pregnancy
lactation severe liver impairment |
| gptkbp:discoveredBy |
gptkb:Recordati
|
| gptkbp:drugClass |
dihydropyridine
|
| gptkbp:eliminationHalfLife |
8-10 hours
|
| gptkbp:hasMolecularFormula |
C36H41ClN2O6
|
| https://www.w3.org/2000/01/rdf-schema#label |
lercanidipine
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits L-type calcium channels
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
gptkb:C_(Australia)
|
| gptkbp:proteinBinding |
>98%
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
edema
dizziness headache palpitations flushing |
| gptkbp:synonym |
gptkb:Zanidip
|
| gptkbp:usedFor |
hypertension
|
| gptkbp:bfsParent |
gptkb:Zanidip
gptkb:C08CA05 |
| gptkbp:bfsLayer |
7
|